Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
10.03. | Galderma @ AAD 2024: New Data Demonstrate the Long-Term Efficacy of Nemolizumab in Prurigo Nodularis and Its Durability in Atopic Dermatitis | 364 | Business Wire | Nemolizumab is a first-in-class investigational monoclonal antibody designed to provide relief from itch by targeting IL-31
One-year data from an interim analysis of the OLYMPIA long-term... ► Artikel lesen | |
10.03. | Incyte Presents New Late-Breaking Data from Phase 2 Study Evaluating Povorcitinib in Patients with Prurigo Nodularis | 498 | Business Wire | Randomized Phase 2 study met its primary and secondary endpoints following 16 weeks of treatment across all dosing groups, reinforcing povorcitinib's potential role in treating prurigo nodularis... ► Artikel lesen |
Suchbegriffe der letzen 24 h | Anzahl |
---|---|
EVOTEC | 472 |
NVIDIA | 308 |
DEUTSCHE BANK | 306 |
BAYER | 237 |
NEL | 215 |
TESLA | 209 |
RHEINMETALL | 161 |
TUI | 160 |
BYD | 158 |
SUPER MICRO COMPUTER | 157 |
THYSSENKRUPP | 141 |
BASF | 128 |
COMMERZBANK | 121 |
PLUG POWER | 121 |
MICROSOFT | 116 |
AIXTRON SE | 114 |
GALERIA KARSTADT KAUFHOF GMBH | 114 |
AMAZON | 112 |
INTEL | 107 |
RWE | 103 |
META PLATFORMS | 102 |
ALPHABET | 101 |
DELIVERY HERO | 95 |
PAYPAL | 94 |
VARTA | 86 |